Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention
Cancer Medicine · 2026
DOI: 10.1002/cam4.71573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2026. Verfasst von Ambulugala Gamage Rajika Greshamali Jinadasa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Faculty of Allied Health Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka. Hauptthemen laut MEDLINE: Metformin, Breast Neoplasms, Hypoglycemic Agents, Antineoplastic Agents. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sri Jayewardenepura, Sri Lanka, University of Sri Jayewardenepura.
Abstract (Originalsprache)
Introduction
Metformin, the common anti‐hyperglycemic agent, is emerging with pharmacological significance as an effective anti‐cancer modulator. Its efficacy as an anti‐cancer modulator is reported in pre‐clinical and clinical studies. Therefore, an attempt was made to identify the possible in vitro anti‐cancer molecular mechanisms studied on breast cancer (BC) cell lines.
Methods
An advanced literature search was conducted in the PubMed database using search terms “Metformin, Cell culture, Breast neoplasms.” Different anti‐cancer molecular mechanisms induced by metformin (MET) identified in cell culture studies are presented in this paper.
Results
It was identified that MET induces molecular pathways that exert anti‐cancer effects when treated on BC cells. Inhibition of oxidative phosphorylation, adenosine monophosphate‐activated protein kinase mediated anticancer effects, anti‐proliferation and inhibition of cell migration, alteration of tumor micro‐environment, synergetic effects with conventional chemotherapies and other potential molecules, induced apoptosis and ferroptosis were mainly identified as MET‐induced pathways that affect BC cells.
Conclusion
Metformin induces diverse anti‐cancer biochemical pathways through which it exhibits a potential to be used as an anti‐cancer therapeutic in BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Sciences, Faculty of Allied Health Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
- Department of Biochemistry, Faculty of Medicine, Sabaragamuwa University of Sri Lanka, Ratnapura, Sri Lanka.
- Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo, Sri Lanka.
- Department of Biochemistry, Faculty of Medical Science, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
- Rural Health Research Institute, Charles Sturt University, Orange, New South Wales, Australia.
ORCID-Profile: Ambulugala Gamage Rajika Greshamali Jinadasa, N D Amal Wageesha, Sameera R Samarakoon, Sagarika Ekanayake, H M Kasuni Akalanka
Förderung
- University of Sri Jayewardenepura, Sri Lanka
- University of Sri Jayewardenepura
Zitieren
APA
Jinadasa, A. G. R. G., Wageesha, N. D. A., Samarakoon, S. R., Ekanayake, S., & Akalanka, H. M. K. (2026). Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. Cancer Medicine. https://doi.org/10.1002/cam4.71573
Vancouver
Jinadasa AGRG, Wageesha NDA, Samarakoon SR, Ekanayake S, Akalanka HMK. Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. Cancer Medicine. 2026. doi:10.1002/cam4.71573
BibTeX
@article{Jinadasa2026,
author = {Jinadasa, Ambulugala Gamage Rajika Greshamali and Wageesha, N D Amal and Samarakoon, Sameera R and Ekanayake, Sagarika and Akalanka, H M Kasuni},
title = {Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71573}
}
EUVIMED